SCHEMBL3545556

SCHEMBL3545556

CN(C)c1nc(S)c(C#N)c(-c2ccccc2)c1C#N

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.49
L3MBTL1 Q9Y468 1/20 0.49
NPSR1 Q6W5P4 3/20 0.48
HPGD P15428 3/20 0.48
RXFP1 Q9HBX9 3/20 0.47
KDM4E B2RXH2 8/20 0.43
ALDH1A1 P00352 7/20 0.43
LMNA P02545 4/20 0.43
NCOA3 Q9Y6Q9 1/20 0.43
HSD17B10 Q99714 4/20 0.42
ADORA2A P29274 4/20 0.42
HTT P42858 2/20 0.42
ADRA2A P08913 2/20 0.42
CYP1A2 P05177 3/20 0.42
CYP2C19 P33261 3/20 0.42
CYP3A4 P08684 2/20 0.42
CYP2D6 P10635 2/20 0.42
CYP2C9 P11712 2/20 0.42
TSHR P16473 2/20 0.42
MEN1 O00255 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3544024 0.77 L3MBTL1 (0.45) TDP1L3MBTL1NPSR1HPGDRXFP1
SCHEMBL245321 0.76 ADORA2A (0.60) NPSR1HPGDRXFP1KDM4EALDH1A1
SCHEMBL1421642 0.76 SQOR (0.56) L3MBTL1NPSR1HPGDRXFP1KDM4E
SCHEMBL3547643 0.73 ADORA1 (0.68) MEN1KMT2AADORA1
SCHEMBL12681373 0.70 ALDH1A1 (0.55) NPSR1HPGDRXFP1KDM4EALDH1A1
SCHEMBL16984845 0.70 ALDH1A1 (0.55) NPSR1HPGDRXFP1KDM4EALDH1A1
SCHEMBL7011406 0.70 ADORA2A (0.70) HPGDRXFP1KDM4EALDH1A1LMNA
SCHEMBL1034013 0.68 ALDH1A1 (0.53) NPSR1HPGDRXFP1KDM4EALDH1A1
SCHEMBL19717017 0.68 DNMT1 (0.43) TDP1L3MBTL1NPSR1HPGDRXFP1
SCHEMBL16295335 0.68 KDM4E (0.71) NPSR1HPGDKDM4EALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7825255-B2 Adenosine receptor selective modulators BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2010-11-02 US disclosed
US-7825255-B2 Adenosine receptor selective modulators BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2010-11-02 US disclosed
US-7825255-B2 Adenosine receptor selective modulators BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2010-11-02 US disclosed
EP-1368319-B1 SUBSTITUTED 2-THIO-3,5-DICYANO-4-ARYL-6-AMINOPYRIDINES AND THEIR USE AS ADENOSINE RECEPTOR-SELECTIVE LIGANDS BAYER HEALTHCARE AG (DE) 2006-12-06 EP disclosed
US-20060154969-A1 Adenosine receptor selective modulators BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2006-07-13 US disclosed
EP-1368319-A1 SUBSTITUTED 2-THIO-3,5-DICYANO-4-ARYL-6-AMINOPYRIDINES AND THEIR USE AS ADENOSINE RECEPTOR-SELECTIVE LIGANDS Bayer Aktiengesellschaft (DE) 2003-12-10 EP disclosed
WO-2002070485-A1 SUBSTITUTED 2-THIO-3,5-DICYANO-4-ARYL-6-AMINOPYRIDINES AND THEIR USE AS ADENOSINE RECEPTOR-SELECTIVE LIGANDS BAYER AKTIENGESELLSCHAFT (DE) 2002-09-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060154969-A1 Adenosine receptor selective modulators ADORA2A, ADORA1, ADORA3 TDP1 2279/4885L3MBTL1 4871/4885NPSR1 63/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.